Selegline is selectively inhibits MAO-B at low to moderate doses. It does not inhibit MAO-A at all. When administered with levodopa, it enhances the actions of levodopa, reduces the required dose. At recommended doses has little potential for causing hypertensive crises. Select one:
[Answered]: Selegline is selectively inhibits MAO-B at low to…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.